Fig. 2

A Overall survival of patients with HCC treated with the combination of one-shot CDDP chemotherapy via HAI and RT, divided by the first-time response of tumor thrombus in the portal vein PR/SD. B Overall survival of patients with HCC treated with the combination of one-shot CDDP chemotherapy via HAI and RT, divided by the relative tumor volume < 50%/ ≥ 50%. HCC hepatocellular carcinoma; CDDP cisplatin; HAI hepatic arterial infusion; RT radiation therapy; PR partial response; SD stable disease